Amicus Therapeutics, Inc.
FOLD
$9.92
$0.141.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.31M | -24.42M | -21.69M | 14.74M | -6.73M |
| Total Depreciation and Amortization | 1.87M | 1.85M | 1.84M | 2.04M | 2.17M |
| Total Amortization of Deferred Charges | 658.00K | 630.00K | 606.00K | 597.00K | 574.00K |
| Total Other Non-Cash Items | 25.71M | 24.46M | 20.99M | 22.45M | 24.99M |
| Change in Net Operating Assets | -9.89M | -29.05M | 6.01M | -43.74M | -43.98M |
| Cash from Operations | 35.66M | -26.53M | 7.76M | -3.92M | -22.97M |
| Capital Expenditure | -382.00K | -2.40M | -212.00K | -288.00K | -356.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -917.00K | -3.38M | -32.65M | -20.10M | 34.63M |
| Cash from Investing | -1.30M | -5.78M | -32.86M | -20.39M | 34.27M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -17.00K | -8.00K | -15.00K | -43.00K | 24.00K |
| Issuance of Common Stock | 339.00K | 40.00K | 105.00K | 1.97M | 20.96M |
| Repurchase of Common Stock | -1.64M | -432.00K | -11.79M | -828.00K | -2.79M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.32M | -400.00K | -11.70M | 1.10M | 18.19M |
| Foreign Exchange rate Adjustments | -1.20M | 9.99M | 4.82M | 3.11M | -5.03M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 31.84M | -22.72M | -31.98M | -20.10M | 24.46M |